Navigation Links
New Data Show High Frequency of Medical Claims for Gastrointestinal Events by Patients on Antiplatelet Therapy
Date:5/6/2008

et medicines such as clopidogrel or aspirin, and an even higher risk for patients taking clopidogrel in combination with aspirin or other non-steroidal anti-inflammatory drugs (NSAIDS). One study showed that treatment with clopidogrel augmented bleeding caused by NSAIDS, an effect attributed to the inhibition of platelets by clopidogrel.

Increasing age is a recognized risk factor for ulcer disease, and clopidogrel is commonly prescribed for elderly patients with atherosclerosis. In the insurance claim review, 72 percent of patients were over 60 years of age. Information about concurrent aspirin use, which is common among patients with cardiovascular disease and particularly among clopidogrel users, was not available. A higher incidence of bleeding side effects was seen in women -- 7.2 percent filed medical claims for an ulcer or gastrointestinal bleeding while 5.4 percent of men filed claims.

"The surprisingly high frequency of these claims raises a significant public health concern," said Dr. Byron Cryer, the John C. Vanatta III Professor of Medicine and Associate Dean for Minority Affairs at Southwestern Medical School in Dallas. "Until recently, gastrointestinal side effects in patients taking antiplatelet therapy have been largely underappreciated by physicians, who are appropriately focused on preventing future heart attacks. We need to address this problem to help keep patients on their medical treatment regimens."

Dr. Cryer is a member of the Scientific Steering Committee overseeing COGENT, the global Phase 3 clinical trial program sponsored by Cogentus. The COGENT program will evaluate the efficacy and safety of Cogentus's lead product, CGT-2168, which combines clopidogrel and the gastroprotectant omeprazole. CGT-2168 is designed to maintain the cardiovascular benefits of antiplatelet therapy while reducing its potentially serious gastrointestinal side effects.

ABOUT COGENTUS

Cogentus Pharmaceuticals, Inc., of Menlo Park, C
'/>"/>

SOURCE Cogentus Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. New Data Reveal Topical Divigel(R) (estradiol gel) 0.1% Significantly Reduces Frequency and Severity of Hot Flashes
2. Quantum Immunologics, Inc. and the South Alabama Medical Science Foundation Announce an Early Clinical Evaluation of a Novel Immuno-therapeutic Vaccine for Treating Advanced Human Breast Carcinomas
3. Delcath Expands Phase III Trial for Metastatic Melanoma to Include University of Maryland Medical Center
4. Tepha Announces First Human Usage of Medical Devices Derived from New Class of Resorbable Polymers
5. Rib-X Pharmaceuticals Renews Collaborative Agreement with the Medical Research Council
6. Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings
7. Columbia University Medical Center and Rosetta Genomics Announce Columbia Universitys Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica
8. Orqis(R) Medicals Cancion(R) System Significantly Increases Cardiac Performance
9. New York-Presbyterian/Weill Cornell is First New York Medical Center to Offer Tantalus Clinical Trial to Diabetes Patients
10. Stem Cell Research Provides Medical Breakthrough to Repair Heart Cell Damage Created by a Heart Attack
11. Valor Medical Announces First Human Implant of Neucrylate AN(TM) for Treatment of Cerebral Aneurysm
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... CITY, Kan. , March 4, 2015   ... a pet therapeutics company focused on the licensing, development ... today announced that it will present at the ... 10-12, 2015, at the Loews Miami Beach Hotel in ... Steven St. Peter , M.D., President and Chief ...
(Date:3/4/2015)... March 4, 2015  Results of the recent study, ... Using MarginProbe for Intra-Operative Positive Margin Detection , were ... the 32 nd Annual Miami Breast Cancer Conference ... Moshe Papa , MD, FACS, Professor of Surgery ... University, reports an analysis of MarginProbe,s efficiency and accuracy ...
(Date:3/4/2015)... 2015 Aethlon Medical, Inc. (OTCQB:AEMD), the pioneer in ... cancer, today announced that James A. Joyce , ... overview at the 27th Annual ROTH Conference on March ... Laguna Niguel, California . To learn more about ... A live webcast of the presentation will be ...
Breaking Medicine Technology:Aratana Therapeutics to Present at the Barclays Global Healthcare Conference 2New Study Shows Breast Re-excision Rates Significantly Reduced in 100 Consecutive Cases 2Aethlon Medical to Present at the 27th Annual ROTH Conference 2
... April 22 Genoptix, Inc. (Nasdaq: GXDX ), a specialized ... for the first quarter 2010 after closing of the NASDAQ Global Select Market ... , , ... , Ph.D., and other members of senior management will take place on the ...
... REDWOOD CITY, Calif. , April 22 Codexis, Inc. announced today ... stock, at $13.00 per share. All shares are being sold by ... an additional 900,000 shares at the initial public offering price to cover overallotments, ... the symbol "CDXS." , , , ...
Cached Medicine Technology:Genoptix, Inc. to Announce First Quarter 2010 Financial Results 2Genoptix, Inc. to Announce First Quarter 2010 Financial Results 3Codexis, Inc. Announces Pricing of Initial Public Offering 2
(Date:3/4/2015)... Jeannie Mai, TV personality, fashion maven, and co-host ... of the print publication. Mai embraces the overall theme of ... for clothes and personal care products. In an exclusive interview, ... to an organic diet. She mentions, “Having an organic lifestyle ... but also now as I’m a full time student at ...
(Date:3/4/2015)... Today Visiopharm announces that Patrik Dahlén, previously the ... Visiopharm Board of Directors as Chairman. Mr. ... positioned to become the fastest growing software company, specializing ... , "Over the last several years, Visiopharm ... ONCOtopix™ Dx, a complete quantitative digital pathology solution for ...
(Date:3/4/2015)... March 04, 2015 Problem Gambling Awareness ... to join individuals and organizations across the nation in ... public, health care professionals, policymakers, and others about problem ... on Compulsive Gambling (FCCG) and FCCG partner organizations are ... screen patients for a gambling problem, to make treatment ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 A new ... showing promise in terms of extending life. Studies ... that this new dieting routine can help extend life ... production clearly has long term benefits, many suffering from ... a quicker substitute is necessary. As an alternative to ...
(Date:3/4/2015)... 04, 2015 Dietary supplement company ... world’s first biocompatible copper chelate, at Natural Products Expo ... the chance to gain insight into their wellness through ... Cunermuspir complex can support their individual nutritional needs, all ... is the core ingredient of the MitoSynergy product line, ...
Breaking Medicine News(10 mins):Health News:Visiopharm Appoints Patrik Dahlen as Chairman of the Board 2Health News:Visiopharm Appoints Patrik Dahlen as Chairman of the Board 3Health News:Problem Gambling - A Public Health Issue; March Is Problem Gambling Awareness Month 2Health News:Diet Doc Introduces New Alternative to the Feast and Famine Diet 2Health News:Diet Doc Introduces New Alternative to the Feast and Famine Diet 3Health News:MitoSynergy Invites Expo West Attendees to Sit Back, Relax and Take Time for Their Health 2
... scientists have said that degradation of the eco systems// of ... and may cause greater harm in next 50 years. ... a major outbreak and new diseases are emerging because of ... being used in unsustainable way. ,The report emphasizes that ...
... drug raloxifene, used for treating osteoporosis is also able to ... are in their postmenopausal age. ,The study observed women ... mg of raloxifene daily for bone fractures due to osteoporosis ... After three years, all women were tested for cognitive impairments ...
... completed the second phase of testing of the vaccine ... cervical cancers and 90% of genital warts. ,277 ... 36 months and regularly had gynecological examination, cervicovaginal sampling ... antibodies to HPV. , ,The results showed the ...
... onions may be the key to avoid the risk of ... in onions, a peptide called GPCS that seems to prevent ... cells of newborn mice that were treated with parathyroid hormone ... exposed to the peptide GPCS. The treatment with the peptide ...
... In a study trying to find out the relationship between ... 585 confirmed cases of pancreatic cancer and 4779 healthy people ... pancreas is pancreatic cancer and it spreads through the lymphatic ... smoking etc had been known to increase the risk of ...
... the risk of diabetes. Obese people may be a t ... A study by UT Southwestern Medical Center of US suggests ... have a genetic component. ,The study had evaluated ... type II in people. The study was conducted on 679 ...
Cached Medicine News:
... Stryker's cystoscope line combines ... intuitive and durable hardware. ... incorporate a robust, ergonomic ... connection found on Stryker ...
... The new EndoEYE Flexible Video Cystoscope from ... surgical technology. By marrying proprietary video chip ... Olympus is now providing a flexible video ... that of a rigid rod lens system. ...
The Olympus continuous flow cystoscope was especially designed for laser treatment of the prostate and for collagen injection....
... is an advanced transurethral microwave thermotherapy ... benign prostate hyperplasia (BPH). TherMatrx is ... thermotherapy treatment in the United States. ... does not require cutting, heavy sedation ...
Medicine Products: